Long-form guides, side-effect deep-dives, and protocol comparisons for men’s health. No paid posts. No “transform your life” copy. We write what we’d want to read before making a treatment decision — for ourselves or someone in our family. Browse by category, search by keyword, or read everything we’ve published.
Two sessions a week—totaling roughly 30–60 minutes—appears to be the dose at which resistance training delivers its largest mortality benefit. Beyond that threshold, returns diminish fast; below it, you're leaving meaningful protection on the table.
Clinical trials now confirm that omega-3 fatty acids produce real but domain-specific cognitive benefits — strongest in men with early memory complaints, modest in healthy middle-aged adults, and essentially absent in established Alzheimer's disease.
Low-level alcohol consumption — one to two standard drinks per day — measurably accelerates brain aging, reduces total brain volume, and degrades white matter integrity. This is not a fringe position: large neuroimaging datasets now make the structural harm hard to argue away.
For most men with obesity-related low testosterone, semaglutide (Ozempic, Wegovy) raises testosterone rather than suppressing it — by attacking the metabolic root cause of functional hypogonadism.
Tirzepatide (Mounjaro) produces greater weight loss than semaglutide (Ozempic) in men managing both type 2 diabetes and obesity — and the gap is large enough to matter clinically.
Several legitimate non-prescription approaches to erectile dysfunction are backed by controlled trial data — but the gap between evidence and marketing claims is wide. Here's what the research actually supports, ranked by strength of evidence.
Testosterone does improve muscle strength and lean mass in hypogonadal men — the evidence on that point is consistent. What the data do not support is the broader claim that TRT turns average training sessions into elite-level results, or that men with normal testosterone gain…
TRT can meaningfully improve erectile function — but only in the right patient. If your testosterone is genuinely low (below roughly 300 ng/dL) and ED is part of a broader picture of hypogonadism, hormone therapy often restores libido and improves erection quality.
The short answer: Ozempic carries a boxed FDA warning about thyroid C-cell tumors based on rodent data, but human evidence does not currently show a clear, clinically significant increase in thyroid cancer risk for most patients.
For most men with confirmed low testosterone, TRT does improve sex drive — but the effect is real and modest, not dramatic. Meta-analyses of randomized controlled trials in hypogonadal men report standardized mean differences of 0.17–0.23 for libido and sexual activity compared…
Semaglutide activates GLP-1 receptors throughout the brain, and the evidence cuts two ways: observational data consistently link it to lower dementia risk, while the phase 3 EVOKE trials found no benefit in established Alzheimer's disease — and a real subset of patients report…
Yes — low testosterone can cause or worsen erectile dysfunction, but it's rarely the only factor. Roughly 23–36% of men presenting with ED are biochemically hypogonadal, and the two conditions share so many overlapping risk factors that treating one without addressing the other…
Ready to start a protocol?
Connect with vetted online providers for TRT, GLP-1, ED treatment, and more.
One email a week. The research, not the hype.
What we published, what changed in the evidence, and what it means if you are on a protocol.
No spam, no selling your address. Unsubscribe in one click.